These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1088 related items for PubMed ID: 7635770

  • 1. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1309-17. PubMed ID: 7635770
    [Abstract] [Full Text] [Related]

  • 2. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA, Grigsby PW, Castro-Vita H, Lockett MA.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1275-88. PubMed ID: 7635767
    [Abstract] [Full Text] [Related]

  • 3. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.
    Int J Radiat Oncol Biol Phys; 2002 Nov 01; 54(3):780-93. PubMed ID: 12377330
    [Abstract] [Full Text] [Related]

  • 4. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT.
    Gynecol Oncol; 2007 Dec 01; 107(3):458-63. PubMed ID: 17854872
    [Abstract] [Full Text] [Related]

  • 5. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ, Hong JH.
    Gynecol Oncol; 1999 Dec 01; 75(3):328-33. PubMed ID: 10600284
    [Abstract] [Full Text] [Related]

  • 6. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL, Wu LY, Li XG, Zhang R, Li N, Yao HW.
    Zhonghua Zhong Liu Za Zhi; 2012 May 01; 34(5):378-81. PubMed ID: 22883461
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 01; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N.
    Gynecol Oncol; 2004 Jun 01; 93(3):628-31. PubMed ID: 15196855
    [Abstract] [Full Text] [Related]

  • 11. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, DiSaia PJ, Berman ML.
    Gynecol Oncol; 1994 Jul 01; 54(1):4-9. PubMed ID: 8020837
    [Abstract] [Full Text] [Related]

  • 12. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM, Park W, Kim YS, Kim JY, Kim HJ, Kim J, Kim JH, Yoon MS, Choi JH, Yoon WS, Kim JY, Huh SJ.
    Gynecol Oncol; 2014 Mar 01; 132(3):618-23. PubMed ID: 24486605
    [Abstract] [Full Text] [Related]

  • 13. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
    Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA.
    Int J Radiat Oncol Biol Phys; 1998 May 01; 41(2):307-17. PubMed ID: 9607346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L, Lü WG, Xie X, Chen HZ, Yu H, Ni XH.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr 01; 40(4):239-42. PubMed ID: 15924669
    [Abstract] [Full Text] [Related]

  • 16. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T, Ito H, Itami J, Yasuda S, Isobe K, Hara R, Sato T, Minoura S, Shigematsu N, Kubo A.
    Anticancer Res; 2000 Apr 01; 20(3B):2235-9. PubMed ID: 10928184
    [Abstract] [Full Text] [Related]

  • 17. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA.
    Cancer; 2003 May 01; 97(9):2196-202. PubMed ID: 12712471
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M, Xu HD, Pan SD, Lin S, Yue JH, Liu JR.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):966-71. PubMed ID: 22138462
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.